Compare LMAT & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMAT | CENTA |
|---|---|---|
| Founded | 1983 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2006 | 1996 |
| Metric | LMAT | CENTA |
|---|---|---|
| Price | $80.14 | $33.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $107.00 | $46.25 |
| AVG Volume (30 Days) | 188.3K | ★ 221.1K |
| Earning Date | 11-05-2026 | 08-05-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | 30.57 | ★ 57.41 |
| EPS | 1.42 | ★ 2.84 |
| Revenue | $249,602,000.00 | ★ $3,129,100,000.00 |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $9.54 | N/A |
| P/E Ratio | $58.69 | ★ $11.97 |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $78.22 | $25.97 |
| 52 Week High | $118.01 | $40.80 |
| Indicator | LMAT | CENTA |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 25.81 |
| Support Level | $82.58 | $30.92 |
| Resistance Level | $84.35 | $35.28 |
| Average True Range (ATR) | 1.57 | 0.77 |
| MACD | 0.71 | -0.03 |
| Stochastic Oscillator | 94.31 | 3.86 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.